Login to Your Account

Up to $1.4B in Milestones

Molecular Partners Gets $62.5M as Allergan Repeats on Darpins

By Cormac Sheridan
Staff Writer

Wednesday, August 22, 2012
Molecular Partners AG is banking $62.5 million up front and could receive up to $1.4 billion more in development, regulatory and commercial milestones in its second ophthalmology deal with Allergan Inc.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription